Overview

Treatment With Intravitreal Avastin for Large Uveal Melanomas

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of Avastin introduced into the inside of the eyeball in causing shrinkage of the uveal melanoma (tumor of the eye). Avastin is an anti-cancer drug specially designed to shrink blood vessels within tumors.
Phase:
N/A
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Bevacizumab